Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
Trends in pharmacological sciences, 1997 - cell.com
There is now good reason to believe that blockade of the adenosine A 2A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
PJ Richardson, H Kase… - Trends in …, 1997 - pubmed.ncbi.nlm.nih.gov
There is now good reason to believe that blockade of the adenosine A2A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
PJ Richardson, H Kase, PG Jenner - Trends in Pharmacological Sciences, 1997 - cell.com
There is now good reason to believe that blockade of the adenosine A 2A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
[引用][C] Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
PJ Richardson, H Kase, PG Jenner - Trends in Pharmacological …, 1997 - cir.nii.ac.jp
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
PJ Richardson, H Kase, PG Jenner - Trends in Pharmacological Sciences, 1997 - elibrary.ru
There is now good reason to believe that blockade of the adenosine A 2 A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease.
PJ Richardson, H Kase, PG Jenner - Trends in Pharmacological …, 1997 - europepmc.org
There is now good reason to believe that blockade of the adenosine A2A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
Adenosine A 2 A receptor antagonists as new agents for the treatment of Parkinson's disease
PJ Richardson, H Kase, PG Jenner - Trends in Pharmacological Sciences, 1997 - infona.pl
There is now good reason to believe that blockade of the adenosine A 2 A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
PJ Richardson, H Kase, PG Jenner - Trends in Pharmacological Sciences, 1997 - Elsevier
There is now good reason to believe that blockade of the adenosine A2A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
PJ Richardson, H Kase, PG Jenner - Trends in Pharmacological Sciences, 1997 - Elsevier
There is now good reason to believe that blockade of the adenosine A2A receptor could be
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …
of value in the treatment of Parkinson's disease. Peter J. Richardson, Hiroshi Kase and Peter …